High intensity exercise can improve cardiorespiratory fitness, reduce cardiovascular risk and provide psychological benefit in individuals with hypertrophic cardiomyopathy. However, for these positive effects to have a lasting impact, regular exercise must become a consistent habit.
So proud that my PhD work has just been published in EHJ. Thank you to my fantastic supervisory team, collaborators, physiologists and most importantly the incredible participants and cardiac rehabilitation team without whom none of this would be possible.
@MichaelPapadak2@SSharmacardio Dimitra Nikoletou @JODriscoll9@DrMaiteTome@BehrElijah@DrCJMiles@maclachlan_h@parry_williams@escardio@ehj_ed@CityStG_Health@CRY_UK
https://t.co/MSWnd6kmD7
📣 Substantive EP & Devices consultant post now advertising in the world renowned Liverpool Heart and Chest Hospital @LHCHFT@LiverpoolEP
Looking especially for candidates to support the clinical & academic structural heart VT programme
Apply now👇
https://t.co/DU4RNuuFET
#AICC conference November 11th-12th 2024! We hope you can join us in Cambridge for 2 days of ICC updates, networking opportunities and dinner with friends 😊 https://t.co/pddZOgoPQN @AiccUk @eleanorwicks@BehrElijah#CardioTwitter#CardioEd
Cardiomyopathy UK national training day being held in Liverpool 21/10/24. Delegate places extended due to popular demand! Sign up here: https://t.co/uG9A2MGHxU
ICC fellow post now available with the team at LHCH, access to post CCT training in all aspects of ICC with time for developing subspecialist interests in imaging/EP/Devices. Please get in contact if you are interested! https://t.co/lLTlclsl0U
📖 Learn more about established and novel therapeutic interventions in patients with obstructive #HypertrophicCardiomyopathy, with a focus on percutaneous and surgical strategies 👉 https://t.co/FeA5ceo09Z #HCM#CJC
Interested in the Scientist Training Programme (STP)? Register for our online open day on the 18th Jan to hear from various specialisms about why you should apply to Barts Health! @DrNolanStain @THspiro@Mammacoffee@mdstbarts@ahcsuk@BartsCardiac https://t.co/zHo4vcVPRx
A cardiac arrest can occur at any time to anyone - which is why we're pleased to share details of @FootballFoundtn's @PremierLeague Defibrillator Fund, which supports the installation of AEDs at grassroots facilities.
Learn more 👉 https://t.co/22CfAfX2Vw
📢 Big step forward for cardiomyopathy drug 📢
NICE, has published their final draft guidance on Mavacamten, recommending that Mavacamten is made available for treating symptomatic obstructive HCM in adults.
Learn more: https://t.co/Nr0vYIKy4g
More data to suggest blanket exercise restriction in HCM may not be warranted. Patient selection is important but in this population vigorous exercise did not increase risk of cardiac events. That’s before considering the beneficial effects of exercise! https://t.co/KKzdDFgV2M